Basic Information
| NavDB ID | NA4722 | |
|---|---|---|
| PubChem CID | 127046597 | |
| ChEMBL ID | CHEMBL3798460 | |
| IUPAC Name | (3S)-3-amino-4-[[(1R,4S,10S,13S,16S,19S,22S,25R,30R,33S,36S,39S,42S,45S,48S,51R,54S,57S,60S,63S,69S,72R,77R,80S,86S,89S,92S,95S)-30-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]carbamoyl]-22,95-bis(4-aminobutyl)-16,60-bis(2-amino-2-oxoethyl)-36-(3-amino-3-oxopropyl)-86-benzyl-4-[(2S)-butan-2-yl]-45,69,92-tris(3-carbamimidamidopropyl)-13,19-bis(carboxymethyl)-42-[(1R)-1-hydroxyethyl]-48-(hydroxymethyl)-39-(1H-imidazol-5-ylmethyl)-33-(1H-indol-3-ylmethyl)-57,80-bis(2-methylpropyl)-89-(2-methylsulfanylethyl)-2,3a,5,11,14,17,20,23,32,35,38,41,44,47,50,53,56,59,62,68,71,78,81,84,87,90,93,96-octacosaoxo-54-propan-2-yl-a,27,28,74,75,99-hexathia-2a,3,6,12,15,18,21,24,31,34,37,40,43,46,49,52,55,58,61,67,70,79,82,85,88,91,94,97-octacosazapentacyclo[49.46.4.225,72.06,10.063,67]trihectan-77-yl]amino]-4-oxobutanoic acid | |
| Molecular Formula | C175H267N53O46S7 |
|
| Molecular Weight | 4074.0 | |
| IC50/EC50* (nM) | 4400 | |
| Target | Nav1.4 | |
| Binding Site | VSDII | |
| Organism | Human | |
| UniProt Name | SCN4A_HUMAN | |
| UniProt ID | P35499 | |
| SMILES | CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C(N)=O)C(C)C)NC(=O)[C@H](Cc2c[nH]c4ccccc24)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC3=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C1=O | |
| Category | Toxins and derivatives | |
| InChI | InChI=1S/C175H267N53O46S7/c1-13-90(10)138-172(274)228-61-32-46-128(228)167(269)214-119(74-135(240)241)156(258)211-116(71-130(181)233)153(255)212-118(73-134(238)239)155(257)200-103(41-24-27-56-178)146(248)218-124-82-279-277-80-122(160(262)202-101(39-22-25-54-176)144(246)209-113(67-94-47-49-97(231)50-48-94)158(260)224-136(88(6)7)168(270)206-109(140(183)242)65-92-33-16-14-17-34-92)220-151(253)114(68-95-75-194-100-38-21-20-37-98(95)100)210-147(249)106(51-52-129(180)232)203-152(254)115(69-96-76-190-85-196-96)215-170(272)139(91(11)230)226-149(251)105(43-29-58-192-174(186)187)201-159(261)120(78-229)216-163(265)125-83-280-281-84-126(165(267)225-138)219-145(247)102(40-23-26-55-177)198-143(245)104(42-28-57-191-173(184)185)199-148(250)107(53-62-275-12)204-150(252)112(66-93-35-18-15-19-36-93)197-132(235)77-195-142(244)110(63-86(2)3)207-162(264)121(217-141(243)99(179)70-133(236)237)79-276-278-81-123(221-164(124)266)161(263)205-108(44-30-59-193-175(188)189)171(273)227-60-31-45-127(227)166(268)213-117(72-131(182)234)154(256)208-111(64-87(4)5)157(259)223-137(89(8)9)169(271)222-125/h14-21,33-38,47-50,75-76,85-91,99,101-128,136-139,194,229-231H,13,22-32,39-46,51-74,77-84,176-179H2,1-12H3,(H2,180,232)(H2,181,233)(H2,182,234)(H2,183,242)(H,190,196)(H,195,244)(H,197,235)(H,198,245)(H,199,250)(H,200,257)(H,201,261)(H,202,262)(H,203,254)(H,204,252)(H,205,263)(H,206,270)(H,207,264)(H,208,256)(H,209,246)(H,210,249)(H,211,258)(H,212,255)(H,213,268)(H,214,269)(H,215,272)(H,216,265)(H,217,243)(H,218,248)(H,219,247)(H,220,253)(H,221,266)(H,222,271)(H,223,259)(H,224,260)(H,225,267)(H,226,251)(H,236,237)(H,238,239)(H,240,241)(H4,184,185,191)(H4,186,187,192)(H4,188,189,193)/t90-,91+,99-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,136-,137-,138-,139-/m0/s1 | |
| InChI Key | WRIRITPBFYZFNI-HTFUMWKFSA-N | |
| Article DOI | 10.1021/acs.jmedchem.5b01947 | |
| PMID | 26890998 | |
| Authors | Murray, JK; Long, J; Zou, A; Ligutti, J; Andrews, KL; Poppe, L; Biswas, K; Moyer, BD; McDonough, SI; Miranda, LP | |
| Institution | Amgen Inc | |
Calculated Properties
| Heavy Atom Count | 281 | Computed by RDKit |
|---|---|---|
| Ring Count | 11 | Computed by RDKit |
| Hydrogen Bond Acceptor Count | 58 | Computed by RDKit |
| Hydrogen Bond Donor Count | 56 | Computed by RDKit |
| Rotatable Bond Count | 71 | Computed by RDKit |
| logP | -2.34 | Computed by ADMETlab3.0 |
| logS | -3.58 | Computed by ADMETlab3.0 |
| logD | -1.43 | Computed by ADMETlab3.0 |
| pKa_acidic | 3.62 | Computed by ADMETlab3.0 |
| pKa_basic | 6.20 | Computed by ADMETlab3.0 |
| Blood-Brain Barrier (BBB) | 0.00 | Computed by ADMETlab3.0 |
| Plasma Protein Binding (PPB) | -43.32 | Computed by ADMETlab3.0 |
| T1/2 | 14.38 | Computed by ADMETlab3.0 |